These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25916523)

  • 41. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders.
    Wilder-Smith CH
    Gut; 2011 Nov; 60(11):1589-99. PubMed ID: 21768212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
    Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
    Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.
    Mearin F
    Digestion; 2006; 73 Suppl 1():28-37. PubMed ID: 16498250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
    Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
    Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenomics in gastrointestinal disorders.
    Schreiber S; Costello CM
    Eur J Surg Suppl; 2002; (587):70-6. PubMed ID: 16144204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapy for functional gastrointestinal disorders in children.
    Chitkara DK; Di Lorenzo C
    Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a causal link between psychological disorders and functional gastrointestinal disorders?
    Wouters MM; Boeckxstaens GE
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):5-8. PubMed ID: 26569404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.
    Katzka DA; Loftus EV; Camilleri M
    Clin Pharmacol Ther; 2012 Sep; 92(3):306-20. PubMed ID: 22828717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebellar aminergic neuromodulation: towards a functional understanding.
    Schweighofer N; Doya K; Kuroda S
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):103-16. PubMed ID: 15003388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional gastrointestinal disorders as a public health problem.
    Talley NJ
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():121-9. PubMed ID: 18402649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain research in functional gastrointestinal disorders.
    Ringel Y
    J Clin Gastroenterol; 2002 Jul; 35(1 Suppl):S23-5. PubMed ID: 12184135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric gastrointestinal motility--future directions and challenges.
    Youssef NN; Di Lorenzo C
    Dig Dis; 2006; 24(3-4):308-12. PubMed ID: 16849858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drugs targeting functional bowel disorders: lessons from drug trials.
    Camilleri M
    Curr Opin Pharmacol; 2002 Dec; 2(6):684-90. PubMed ID: 12482731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of food in the functional gastrointestinal disorders: introduction to a manuscript series.
    Chey WD
    Am J Gastroenterol; 2013 May; 108(5):694-7. PubMed ID: 23545712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.
    Halder SL; Locke GR; Schleck CD; Zinsmeister AR; Melton LJ; Talley NJ
    Gastroenterology; 2007 Sep; 133(3):799-807. PubMed ID: 17678917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insight in the pathogenesis of functional gastrointestinal disorders: association between genetics and colonic transit.
    Wouters MM
    Neurogastroenterol Motil; 2011 Oct; 23(10):893-7. PubMed ID: 21914040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.